CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Series A Preferred Stock	Series B Preferred Stock	Series D Preferred Stock	Series E Preferred Stock	Common Stock	Total Stockholders’ Equity	Total Stockholders’ Equity Series A Preferred Stock	Total Stockholders’ Equity Series B Preferred Stock	Total Stockholders’ Equity Series D Preferred Stock	Total Stockholders’ Equity Series E Preferred Stock	Total Stockholders’ Equity Common Stock	Preferred Stock Series A Preferred Stock	Preferred Stock Series B Preferred Stock	Preferred Stock Series D Preferred Stock	Preferred Stock Series E Preferred Stock	Common Stock	Common Stock Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Series A Preferred Stock	Accumulated Deficit Series B Preferred Stock	Accumulated Deficit Series D Preferred Stock	Accumulated Deficit Series E Preferred Stock	Accumulated Deficit Common Stock	Non-controlling interest
Beginning balance (in shares) at Dec. 31, 2023													6,799,467	4,695,887	7,933,711	4,595,175		230,885,197
Beginning balance at Dec. 31, 2023	$ 2,639,149						$ 2,637,752						$ 68	$ 47	$ 79	$ 46		$ 3,639	$ 4,350,112	$ (14,096)	$ (1,702,143)						$ 1,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared, common stock						$ (209,399)						$ (209,399)									(209,399)
Dividends declared, preferred stock		$ (9,243)	$ (6,054)	$ (11,157)	$ (6,354)			$ (9,243)	$ (6,054)	$ (11,157)	$ (6,354)											$ (9,243)	$ (6,054)	$ (11,157)	$ (6,354)
Equity-based compensation, net of forfeitures (in shares)																	2,906
Equity-based compensation, net of forfeitures	6,622						5,262												5,262								1,360
Common stock shares withheld upon vesting of restricted stock (in shares)																	(69,905)
Common stock shares withheld upon vesting of restricted stock	(552)						(552)										$ (1)		(551)
Distributions to non-controlling interest holders	(105)																										(105)
Net loss	(125,050)						(125,050)														(125,050)
Cumulative translation adjustment	14,069						14,069													14,069
Designated derivatives, fair value adjustments	(16,724)						(16,724)													(16,724)
Ending balance (in shares) at Sep. 30, 2024													6,799,467	4,695,887	7,933,711	4,595,175		230,818,198
Ending balance at Sep. 30, 2024	2,275,202						2,272,550						$ 68	$ 47	$ 79	$ 46		$ 3,638	4,354,823	(16,751)	(2,069,400)						2,652
Beginning balance (in shares) at Jun. 30, 2024													6,799,467	4,695,887	7,933,711	4,595,175		230,805,375
Beginning balance at Jun. 30, 2024	2,423,264						2,421,033						$ 68	$ 47	$ 79	$ 46		$ 3,638	4,353,095	(6,833)	(1,929,107)						2,231
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared, common stock						$ (63,722)						(63,722)														$ (63,722)
Dividends declared, preferred stock		$ (3,081)	$ (2,018)	$ (3,719)	$ (2,118)			(3,081)	(2,018)	(3,719)	(2,118)											(3,081)	(2,018)	(3,719)	(2,118)
Equity-based compensation, net of forfeitures (in shares)																	19,381
Equity-based compensation, net of forfeitures	2,309						1,856												1,856								453
Common stock shares withheld upon vesting of restricted stock (in shares)																	(6,558)
Common stock shares withheld upon vesting of restricted stock	(128)						(128)												(128)
Distributions to non-controlling interest holders	(32)																										(32)
Net loss	(65,635)						(65,635)														(65,635)
Cumulative translation adjustment	12,571						12,571													12,571
Designated derivatives, fair value adjustments	(22,489)						(22,489)													(22,489)
Ending balance (in shares) at Sep. 30, 2024													6,799,467	4,695,887	7,933,711	4,595,175		230,818,198
Ending balance at Sep. 30, 2024	2,275,202						2,272,550						$ 68	$ 47	$ 79	$ 46		$ 3,638	4,354,823	(16,751)	(2,069,400)						$ 2,652
Beginning balance (in shares) at Dec. 31, 2024													6,799,467	4,695,887	7,933,711	4,595,175		231,051,139
Beginning balance at Dec. 31, 2024							2,186,958						$ 68	$ 47	$ 79	$ 46		$ 3,640	4,359,264	(25,844)	(2,150,342)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchases, net (in shares)																	(10,940,881)
Common stock repurchases, net							(82,900)					(82,913)					$ (109)		(82,804)
Dividends declared, common stock							(149,822)														(149,822)
Dividends declared, preferred stock								(9,243)	(6,054)	(11,157)	(6,353)											(9,243)	(6,054)	(11,157)	(6,353)
Equity-based compensation, net of forfeitures (in shares)																	297,747
Equity-based compensation, net of forfeitures							8,663										$ 3		8,660
Common stock shares withheld upon vesting of restricted stock (in shares)																	(52,483)
Common stock shares withheld upon vesting of restricted stock							(811)										$ (1)		(810)
Net loss	(273,638)						(273,638)														(273,638)
Cumulative translation adjustment							44,019													44,019
Designated derivatives, fair value adjustments	1,362						1,362													1,362
Ending balance (in shares) at Sep. 30, 2025													6,799,467	4,695,887	7,933,711	4,595,175		220,355,522
Ending balance at Sep. 30, 2025							1,701,011						$ 68	$ 47	$ 79	$ 46		$ 3,533	4,284,310	19,537	(2,606,609)
Beginning balance (in shares) at Jun. 30, 2025													6,799,467	4,695,887	7,933,711	4,595,175		221,224,341
Beginning balance at Jun. 30, 2025							1,832,379						$ 68	$ 47	$ 79	$ 46		$ 3,541	4,288,338	33,452	(2,493,192)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchases, net (in shares)																	(868,819)
Common stock repurchases, net							(6,900)					$ (6,940)					$ (8)		(6,932)
Dividends declared, common stock							(42,366)														(42,366)
Dividends declared, preferred stock								$ (3,081)	$ (2,018)	$ (3,719)	$ (2,117)											$ (3,081)	$ (2,018)	$ (3,719)	$ (2,117)
Equity-based compensation, net of forfeitures							3,059												3,059
Common stock shares withheld upon vesting of restricted stock							(155)												(155)
Net loss	(60,116)						(60,116)														(60,116)
Cumulative translation adjustment							(14,725)													(14,725)
Designated derivatives, fair value adjustments	$ 810						810													810
Ending balance (in shares) at Sep. 30, 2025													6,799,467	4,695,887	7,933,711	4,595,175		220,355,522
Ending balance at Sep. 30, 2025							$ 1,701,011						$ 68	$ 47	$ 79	$ 46		$ 3,533	$ 4,284,310	$ 19,537	$ (2,606,609)